Detalimogene voraplasmid

沃米德他基

Report date: 2025/09/18 15:54:10

Base Information

Drug NameDetalimogene voraplasmid
Drug Alias NameEG-70
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[10
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesenGene Inc
China Registration ClassN/A

Develop Information

Active CompaniesenGene Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A